VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+2.23%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$36.8B
AUM Growth
+$2.43B
(+7.1%)
Cap. Flow
+$2.8B
Cap. Flow
% of AUM
7.61%
Top 10 Holdings %
Top 10 Hldgs %
28.22%
Holding
1,252
New
233
Increased
711
Reduced
271
Closed
25
Top Buys
| 1 |
TSMC
TSM
|
+$304M |
| 2 |
NVIDIA
NVDA
|
+$201M |
| 3 |
Intel
INTC
|
+$148M |
| 4 |
Advanced Micro Devices
AMD
|
+$126M |
| 5 |
Qualcomm
QCOM
|
+$123M |
Top Sells
| 1 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$148M |
| 2 |
AngloGold Ashanti
AU
|
+$109M |
| 3 |
Kinross Gold
KGC
|
+$90.4M |
| 4 |
Charles Schwab
SCHW
|
+$80.1M |
| 5 |
Applied Materials
AMAT
|
+$78.1M |
Sector Composition
| 1 | Materials | 43.4% |
| 2 | Technology | 21.08% |
| 3 | Healthcare | 6.17% |
| 4 | Energy | 5.2% |
| 5 | Financials | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Labcorp
LH
$22.7B
| $690K | ﹤0.01% |
+3,147
| New | +$690K |
|
802
SEI Investments
SEIC
$10.7B
| $676K | ﹤0.01% |
11,093
+957
| +9% | +$58.3K |
|
|
NIQ
803
DELISTED
NUVEEN INTERMEDIATE DURATION QUALITY MUNICIPAL TERM FUND
NIQ
| $671K | ﹤0.01% |
45,788
+3,745
| +9% | +$54.9K |
|
804
Align Technology
ALGN
$9.64B
| $662K | ﹤0.01% |
+1,223
| New | +$662K |
|
805
Hawaiian Electric Industries
HE
$2.08B
| $662K | ﹤0.01% |
14,919
+179
| +1% | +$7.94K |
|
806
Hologic
HOLX
$14.6B
| $660K | ﹤0.01% |
8,868
-57
| -0.6% | -$4.24K |
|
807
Idacorp
IDA
$6.76B
| $658K | ﹤0.01% |
6,586
+554
| +9% | +$55.4K |
|
808
Sun Life Financial
SLF
$33B
| $658K | ﹤0.01% |
13,007
+2,317
| +22% | +$117K |
|
|
HZNP
809
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $657K | ﹤0.01% |
+7,139
| New | +$657K |
|
810
Humana
HUM
$32.9B
| $657K | ﹤0.01% |
1,566
+298
| +24% | +$125K |
|
811
Huntington Ingalls Industries
HII
$10.7B
| $656K | ﹤0.01% |
3,189
+274
| +9% | +$56.4K |
|
812
Universal Health Services
UHS
$11.8B
| $648K | ﹤0.01% |
+4,859
| New | +$648K |
|
813
Repligen
RGEN
$6.76B
| $645K | ﹤0.01% |
+3,316
| New | +$645K |
|
814
HCA Healthcare
HCA
$92.3B
| $644K | ﹤0.01% |
+3,422
| New | +$644K |
|
|
LINX
815
DELISTED
Linx S.A.
LINX
| $643K | ﹤0.01% |
96,825
-13,503
| -12% | -$89.7K |
|
816
Revvity
RVTY
$9.58B
| $642K | ﹤0.01% |
5,007
+417
| +9% | +$53.5K |
|
817
Bio-Rad Laboratories Class A
BIO
$7.49B
| $641K | ﹤0.01% |
1,122
+48
| +4% | +$27.4K |
|
818
Cooper Companies
COO
$13.5B
| $633K | ﹤0.01% |
+6,596
| New | +$633K |
|
819
Masimo
MASI
$7.92B
| $628K | ﹤0.01% |
2,736
+351
| +15% | +$80.6K |
|
820
MakeMyTrip
MMYT
$9.1B
| $628K | ﹤0.01% |
19,875
-2,312
| -10% | -$73.1K |
|
821
iShares MSCI Switzerland ETF
EWL
$1.33B
| $617K | ﹤0.01% |
13,954
-4,203
| -23% | -$186K |
|
822
APA Corp
APA
$8.33B
| $614K | ﹤0.01% |
34,306
+4,125
| +14% | +$73.8K |
|
823
Boston Scientific
BSX
$156B
| $610K | ﹤0.01% |
15,784
+3,887
| +33% | +$150K |
|
824
Alcoa
AA
$8.01B
| $609K | ﹤0.01% |
18,752
+13,611
| +265% | +$442K |
|
825
Capital One
COF
$143B
| $607K | ﹤0.01% |
4,774
-1,578
| -25% | -$201K |
|